
Venture capital · Early stage · Est. 2018
Jeito Capital
Paris-based independent investment firm dedicated to biopharma, financing and supporting medical innovation companies, mainly in Europe and the United States.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Jeito Capital right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
BetaRounds Jeito Capital joined, from press and the firm’s own posts.
2 rounds in the last 12 months
Round sizes, Jeito Capital’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Jeito Capital backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Jeito Capital
Events where Jeito Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Jeito Capital is based in Paris, France.
In 2018.
2 fund vehicles are on public registers (SEC adviser filings), including JEITO S.L.P. and JEITO II S.L.P.
Stages: Series A. Sectors: Biotech. From the firm’s own website.
Backs ground-breaking biopharma and medical innovation with a patient-benefit-driven approach, providing significant capital and continued support from clinical development through market access, backed by a multidisciplinary team covering the whole drug value chain, aiming to build leaders in therapeutic areas. From the firm’s own website.
Jeito Capital lists 23 portfolio companies on its website, including Neogene Therapeutics, Sparing Vision, Pulmocide, Alentis Therapeutics and Quell Therapeutics.
Firms whose websites list some of the same companies include Catalio Capital Management, AdBio and BioGeneration Ventures.
Know before Jeito Capital’s next round is announced.
PRO tracks Jeito Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.